Enhanced expression of cytokines may play a fundamental role in the mechanisms of immunologically mediated recurrent spontaneous abortion

Acta Obstetricia et Gynecologica Scandinavica

Volumn 76, Issue 3, 1997, Pages 205-211

  Shaarawy, Mohamed ^a,b   Nagui, Abdel Rehim ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b Roxy Building ^*  (Egypt)

Author keywords

Cytokines; Neopterin; Recurrent spontaneous abortion

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; NEOPTERIN; SPERM ANTIBODY; SPERM ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; EMBRYO DEVELOPMENT; ENDOMETRIUM; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; IMMUNORADIOMETRIC ASSAY; LYMPHOCYTE; MACROPHAGE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RECURRENT ABORTION; TROPHOBLAST; UTERINE CERVIX MUCUS;

EID: 0030895313     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0412.1997.tb07846.x     Document Type: Article

References (57)

1. Rock JA, Jacur HA. The clinical management of repeated early pregnancy wastage. Fertil Steril 1983; 39: 123-7.
2. Alberman E. The epidemiology of repeated abortion. In: Sharp F, Beard RW (eds): Early pregnancy loss: mechanism and treatment. New York: Springer-Verlag, 1988; pp. 9-17.
3. Regan L, Oven EJ, Jacobs HS. Hypersecretion of luteinizing hormone, infertility and miscarriage. Lancet 1990; 336: 1141-5.
4. Stray-Pedersen B, Lorentzen-Styr A. Uterine toxoplasma infection and repeated abortions. Am J Obstet Gynecol 1977; 128: 716-21.
5. Nahmias AJ, Josdey WE, Naib ZM et al. Peritoneal risk associated with maternal genital herpes simplex virus infection. Am J Obstet Gynecol 1971; 110: 825-39.
6. Thomas R, Reid RL. Thyroid disease and reproductive dysfunction: A review. Obstet Gynecol 1987; 70: 789-98.
7. Dicker D, Feldberg D, Samuel N et al. Spontaneous abortion in patients with insulin-dependent diabetes mellitus: The effect of preconceptional diabetic control. Am J Obstet Gynecol 1988; 158: 1161-72.
8. Horta JLH, Fernandez JG, De Soto LB. Direct evidence of luteal insufficiency in women with habitual abortion. Obstet Gynecol 1977; 49: 705-9.
9. Tho PT, Byrd JR, McDonough PG. Etiologic and subsequent reproductive reform of 100 couples with recurrent abortion. Fertil Steril 1979; 32: 389-95.
10. Maier DB, Park A. Subclinical autoimmunity in recurrent aborters. Fertil Steril 1989; 51: 280-6.
11. Hill JA, Anderson DJ. The embryo as an immunologic target in infertility and recurrent abortion. In: Mathur S, Fredericks CM (eds). Perspectives in immunoreproduction: Conception and Contraception. New York, Hemisphere Publishing Corp 1988, pp. 261-77.
12. Stray-Pedersen B, Stray-Pedersen S. Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol 1984; 148: 140-6.
13. Nicholas NS. Human fetal allograft survival. In: John Studd (ed) Progress in Obstetrics and Gynaecology. London, Churchill Livingstone 1989; Vol. 7, p. 18.
14. Hill JA, Haimovici F, Anderson DJ. Products of activated lymphocytes and macrophages inhibit mouse embryo development in vitro. J Immunol 1987; 139(7): 2250-4.
15. Berkowitz RA, Hill JA, Kurtz CB, Anderson DJ. Effects of products of activated leukocytes (lymphokines and monokines) on the growth of malignant trophoblast cells in vitro. Am J Obstet Gynecol 1988; 158: 199-203.
16. Anderson DJ, Hill JA, Haimovici F, Xu C. Application of new concepts in cell mediated immunity to the development of effective antifertility vaccines. In: Rhunnbaum B, Rab T, Kiessel L (eds). Female contraception, update and trends Berlin Springer-Verlag 1988; p. 351.
17. Hill JA, Polgar K, Harlow BL, Anderson DJ. Evidence of embryo-and trophoblast-toxic cellular immune response(s) in women with recurrent spontaneous abortion. Am J Obstet Gynecol 1992; 166(4): 1044-52.
18. Head JR. Can trophoblast be killed by cytotoxic cells? In vitro evidence and in vivo possibilities. Am J Reprod Immunol 1989; 20: 110-5.
19. Shiomura K, Manda T, Mukumoto S, Robayashi K, Nakanok K, Mori J. Recombinant human tumor necrosis factor-α: Thrombus formation is a cause of anti-tumor activity. Int J Cancer 1988; 41: 243-7.
20. Silen MI, Firpo A, Morgello S, Lowry SF, Rancus T. Interleukin-1-α and TNF-α cause placental injury in the rat. Am J Pathol 1989, 135: 239-44.
21. Huber C, Batchelor JR, Fuchs D, Hausen A, Lang A et al. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med 1984; 160: 310-6.
22. Troppmair J, Nachbaur K, Herold M et al. In-vitro and in-vivo studies on the induction of neopterin biosynthesis by cytokines, alloantigens and lipopolysaccharide (LPS). Clin Exp Immunol 1988; 74: 392-7.
23. Fuchs D, Hausen A, Reibnegger G et al. Neopterin as a marker for activated cell-mediated immunity: application in HIV infection. Immunol Today 1988; 9: 150-5.
24. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Fertil Steril 1950; 1: 3-25.
25. Abraham GE, Marlouis GB, Marshall JR. Evaluation of the ovulation and corpus luteum function using measurement of plasma progresterone. Obstet Gynecol 1974; 44: 522-32.
26. Allen JN, Herzyk DJ, Allen ED, Wewers MD. Human whole blood interleukin-1-beta production: kinetics, cell source and comparison with TNF-α. J Lab Clin Med 1992; 119(5): 538-46.
27. Opsijon SL, Wathen NC, Tingulstad S, Wideswang G et al. Tumor necrosis factor, interleukin-1 and interleukin-6 in normal human pregnancy. Am J Obstet Gynecol 1993; 169 (2): 397-404.
28. Fakih H, Baggett B, Holtz G et al. Interleukin-1: a possible role in the infertility associated with endometriosis. Fertil Steril 1987; 47: 213-7.
29. Sueldo CE, Kelly E, Montro L, Subias E et al. Effect of interleukin- 1 on gamete interaction and mouse embryo development. J Reprod Med Obstet Gynecol 1990; 35: 868-72.
30. Schneider KG, Armant DR, Kupper TS, Polan ML. Absence of a direct effect of recombinant interleukins and cultured peritoneal macrophages on early embryonic development in the mouse. Biol Reprod 1989; 40: 825-33.
31. Henderson DC, Sheldon J, Riches P, Hobbs JR. Cytokine, induction of neopterin production. Clin Exp Immunol 1991; 83: 479-82.
32. Lea RG, Clark DA. Macrophages and migratory cells in endometrium relevant to implantation. Bailliere's Clin Obstet Gynaecol 1991; Vol. 5, No.1, March, pp. 25-59.
33. Lala PK, Scordras JM, Graham CH, Lysiak JJ, Parhar RS. Activation of maternal killer cells in the pregnant uterus with chronic indomethacin therapy, IL-2 therapy or a combination therapy is associated with embryonic demise. Cell Immunol 1990; 127: 368-81.
34. Rhagupathy R, Singh B, Barrington-Leigh J, Wegmann TG. Ontogeny and turnover kinetics of paternal H-2k antigenic determinants on the allogenic murine placenta. J Immunol 1981; 127: 2074-9.
35. Clark DA. Are there immune abortions? Res Immunol 1990, 141: 202-7.
36. Drake BL, Head JR. Murine trophoblast cells can be killed by lymphokine activated killer (LAK) cells. J Immunol 1989; 143: 9-14.
37. Kauma S, Matt D, Strom S, Eierman D, Turner T. Interleukin-1β, human leukocyte antigen HLA-DRα, and transforming growth factor-β expression in endometrium, placenta and placental membranes. Am J Obstet Gynecol 1990; 163 (5): 1430-7.
38. Athanasakis I, Bleackley RC, Paetkau V, Guilbert L, Barr PJ, Wegmann TG. The immunostimulatory effect of T cells and T cell lymphokines on murine fetally derived placental cells. J Immunol 1987; 138: 37-44.
39. Halloran PF, Cockfield SM, Madrenas J. The mediators of inflammation [interleukin-1, interferon-α, and tumor necrosis factor] and their relevance to rejection. Transplant Proc 1988; 21: 26-30.
40. Voigt HJ, Steib L. Tumor necrosis factor and pregnancy a contribution to the immunology of reproduction. Arch Gynecol Obstet 1989; 246(4): 223-6.
41. Scuderi P, Sterling KE, Lam KS, Finely PR et al. Raised serum levels of tumor necrosis factor in parasitic infections. Lancet 1986; 13: 1364-5.
42. Warner SJC, Libby P. Human vascular smooth muscle. Target for and source of tumor necrosis factor. J Immunol 1989; 142: 100-10.
43. Zuckerman FA, Head JR. Murine trophoblast resist cell mediated lysis. Resistance to natural cell mediated cytotoxicity. Cell Immunol 1988; 116: 274-86.
44. Sargent IL, Wilkins T, Redman CWG. Maternal immune responses to the fetus in early pregnancy and recurrent miscarriage. Lancet 1988; 2: 1099-104.
45. Girardin E, Grau GE, Dayer JM et al. Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Eng J Med 1988; 319(7): 397-400.
46. Fuith LC, Fuchs D, Hausen A, Hetzel H et al. Neopterin a marker of cell-mediated immune activation in human pregnancy. Int J Fertil 1991; 36(6): 372-5.
47. Canessa A, Bono VD, Miletich F, Pistoia V. Serum cytokines in toxoplasmosis: Increased levels of interferongamma in immunocompetent patients with lymphadenopathy but not in AIDS patients with encephalitis. J Infect Dis 1992; 175: 1168-70.
48. Calderon J, Sheehan KCF, Chance C, Thomas ML et al. Purification and characterization of the human interferongamma receptor from placenta. Proc Natl Acad Sci 1988; 85: 4837-17.
49. Berkowitz RS, Paris HM, Hill JA, Anderson DJ. Localization of leukocytes and cytokines in chorionic villi of normal placentas and complete hydatiform moles. Gynecol Oncol 1990; 37(3): 396-400.
50. Fowler AK, Reed CD, Giron DJ. Identification of an interferon in murine placentas. Nature 1980; 286: 266-72.
51. Trinchieri G, Perussia B. Immune interferon: a pleiotropic lymphokine with multiple effects. Immunol Today 1985; 6: 131-6.
52. Schultz RM. Macrophage activation by interferon. Lymphokine Report 1980; 1: 63-9.
53. Paetkau V, Mills GB. Transplantation immunology: Cytokines and mechanisms of lymphocyte activation. Immunol Allergy Clin North Am 1989; 9(1): 21-13.
54. Aukrust P, Froland SS, Muller F. Raised serum neopterin levels in patients with primary hypogammaglobulinaemia; correlation to other immunological parameters and to clincial and histological features. Clin Exp Immunol 1992; 89: 211-6.
55. Werner ER, Bichler A, Daxenbichler G et al. Determination of neopterin in serum and urine. Clin Chem 1987; 33(1): 62-6.
56. Margrieter R, Fuchs D, Hausen A, Huber Ch et al. Neopterin as a new biochemical marker for diagnosis of allograft rejection: Experience based upon evaluation of 100 consecutive cases. Transplantation 1983; 36: 650-8.
57. Woloszczuk W, Schwarz M, Pohanka E, Kovarik J. Relation of neopterin to gamma interferon serum levels in patients with kidney transplants. In: Wachter H, Curtius HC, Pfleiderer W (eds): Biochemical and Clinical Aspects of Pteridines. New York, Walter de Gruyter, 1985; vol. (4), p. 489.